Skip to main content

UBS Group AG

Position in ORKA — Oruka Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in ORKA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$60,848,175
+$50,436,283 QoQ
Shares Held
639,363
+201.2% QoQ
Ownership
0.966%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#28
of 256 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in ORKA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. ORKA ranks #33 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ORKA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $60,848,175 639,363
2026-03-31 $10,411,892 212,271
2025-12-31 $8,214,403 271,013
2025-09-30 $1,664,548 86,560
2025-06-30 $1,240,341 110,646
2025-03-31 $347,639 33,883
2024-12-31 $487,891 25,162
2023-12-31 ABIO 1,131
2023-09-30 ABIO 125
2023-03-31 ABIO 1,787
2022-12-31 ABIO 1,502
2022-09-30 ABIO 2,619
2022-06-30 ABIO 4,519
2022-03-31 ABIO 5,026
2021-12-31 ABIO 7,584
2021-06-30 ABIO 5,365
2020-12-31 ABIO 1,537
2020-09-30 ABIO 927
2020-03-31 ABIO 31